Childhood-Onset Myasthenia Gravis, a Troublesome
Clinical Entity with Heterogeneity in China

Yayun Cao and Bitao Bu

Mini Review

Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China

Yayun Cao and Bitao Bu*

Department of Neurology, China

Corresponding Author

Received Date:Jaunary 03, 2018; Published Date: January 11, 2019

Abstract

Myasthenia gravis (MG) is a well-known autoimmune disease involving neuromuscular transmission leading to fluctuating muscle weakness and fatigability. With the advent of immunotherapy, majority of MG sufferers will have a good outcome. However, the childhood onset MG (CMG) in China is quite different from that reported in the Western countries in light of onset age distribution, clinical types, responsiveness to immunotherapy and the long-term outcome. The mini-review focuses on the differences of Chinese CMG patients from European cases.

Keywords: myasthenia gravis; Child; Juvenile; Heterogeneity; Chinese; Dug-resistance

Article Details

Citation

Yayun Cao, Bitao Bu. Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China Arch Neurol & Neurosci. 2(3): 2019. ANN.MS.ID.000539.